- Telehealth Visits
- Insurance plan information
Daniel H. Null, MD
Internal Medicine- Telehealth Visits
- Insurance plan information
General Internal Medicine Mount Zion – 1701 Divisadero St.
Daniel H. Null, MD
Internal MedicineGeneral Internal Medicine Mount Zion – 1701 Divisadero St.
- Telehealth Visits
- Insurance plan information
On this page
Education & training
Board certification
- Internal Medicine, American Board of Internal Medicine
Residency
- Internal Medicine, UCSF Medical Center - OMAG
Degree
- MD, UCSF School of Medicine
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 104 reviews
Sort by
- February 23, 20265 out of 5 Stars
Dr Null is an excellent physician, I am very luck to have him as my General Practitioner
- February 21, 20265 out of 5 Stars
Dr Null has been my doctor for years and is a great asset to UCSF.
- February 18, 20265 out of 5 Stars
Dr. Null has been our family internist for many years. I am grateful for is care and concern.
- February 17, 20265 out of 5 Stars
Fine discussion and notes.
- January 17, 20265 out of 5 Stars
Needless to say, Dr. Null is by far the best doctor I have ever seen! Thank you, Dr. Null!
- January 17, 20265 out of 5 Stars
Dan Null is a great doctor. Am so lucky to be under his care
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.